Thor Medical ASA: Ex. right to participate in subsequent offering today

12 Dec 2024 07:00 CET

12.12.2024 07:00:01 CET | Thor Medical ASA | Ex date

Oslo, 12 December 2024. Reference is made to the announcement by Thor Medical
ASA (the "Company") earlier today, 12 December 2024, regarding key information
on a potential subsequent offering of shares in the Company. The shares will be
traded exclusive of the right to participate in a potential subsequent offering
from and including today.

Ex. Date: 12 December 2024

This information is published in accordance with the requirements of the
Continuing Obligations for Oslo Børs.



Contacts

Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440,
brede.ellingseter@thormedical.com



ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.





ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18356876/5406/Download%20announce
ment%20as%20PDF.pdf

More information:
Access the news on Oslo Bors NewsWeb site

634410_Download announcement as PDF.pdf